Edition:
United States

Ocular Therapeutix Inc (OCUL.OQ)

OCUL.OQ on NASDAQ Stock Exchange Global Market

4.91USD
16 Feb 2018
Change (% chg)

-- (--)
Prev Close
$4.91
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
120,515
52-wk High
$11.79
52-wk Low
$3.30

Select another date:

Thu, Feb 8 2018

BRIEF-Summer Road Reports 8.4 Pct Passive Stake In Ocular Therapeutix

* SUMMER ROAD LLC REPORTS 8.4 PERCENT PASSIVE STAKE IN OCULAR THERAPEUTIX INC AS OF JANUARY 29, 2018 - SEC FILING‍​ Source text: (http://bit.ly/2BjW1c4) Further company coverage:

BRIEF-Ocular TherapeutixTM Announces Public Offering Of 6.50 Mln Common Shares

* OCULAR THERAPEUTIXTM ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

BRIEF-Ocular Therapeutix Announces Proposed Public Offering Of Common Stock

* OCULAR THERAPEUTIX™ ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

BRIEF-Ocular Therapeutix Announces Kevin Hanley As Senior Vice President Technical Operations

* OCULAR THERAPEUTIX ANNOUNCES KEVIN HANLEY AS SENIOR VICE PRESIDENT, TECHNICAL OPERATIONS AND NAYMISHA PATEL AS VICE PRESIDENT OF QUALITY Source text for Eikon: Further company coverage:

Ocular Therapeutix gets subpoena from SEC over eye pain drug

Ocular Therapeutix Inc said on Friday the U.S. Securities and Exchange Commission (SEC) had issued a subpoena seeking information about the company's eye-pain drug Dextenza.

BRIEF-Ocular Therapeutix Provides Legal Update

* OCULAR THERAPEUTIX INC - ON DEC. 21, CO WAS SERVED WITH A NEW DERIVATIVE COMPLAINT

Ocular Therapeutix gets subpoena from SEC over eye pain drug

Dec 22 Ocular Therapeutix Inc said on Friday the U.S. Securities and Exchange Commission (SEC) had issued a subpoena seeking information about the company's eye-pain drug Dextenza.

BRIEF-Ocular Therapeutix posts Q3 loss per share $0.54

* Ocular Therapeutix reports third quarter 2017 financial results and provides corporate update

BRIEF-Ocular Therapeutix appoints Donald Notman as chief financial officer

* Ocular Therapeutix appoints Donald Notman as chief financial officer

Select another date: